Release Date: June 28, 2024
Expiration Date: June 28, 2025
Activity Overview
Medical Crossfire®, one of PER’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in spirited discussions and debates on a particular clinical topic. In this activity, 4 key thought leaders explore the latest data regarding current and emerging therapeutic strategies for the management of advanced pancreatic cancer across lines of care. This lively discussion will help place new developments into clinical context to help you optimize care for your patients with pancreatic cancer.
Target Audience
This activity is geared towards oncologists, advanced practitioners, nurses, and other health care workers involved in the care of pancreatic cancer.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Select appropriate first-line therapy for locally advanced or metastatic pancreatic cancer based on relevant biomarkers, clinical and logistical factors
- Develop an evidence-based strategy for the treatment of metastatic pancreatic cancer in patients who experience disease progression on front-line chemotherapy, exploring the importance of age, performance status, and prior therapy exposure
- Explain the biologic rationale and clinical data for investigational agents currently being evaluated in pancreatic cancer
- Identify a plan to recognize and manage adverse effects associated with approved systemic regimens commonly employed in the management of pancreatic cancer to support quality of life and continuation of therapy
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
